– UK, Macclesfield – SkinBioTherapeutics plc (LON: SBTX), a life Science business focusing on skin health, today announced the appointment of Danielle Bekker to its Board as a non-executive director, subject to regulatory due diligence.
“We also look forward to welcoming Danielle to the Board. We have deliberately chosen a NED with FMCG experience since this brings a fresh outlook and varied experience, as well as her extensive network, to our commercialisation plans. She has considerable skills in how to sell to consumers using digital marketing, including influencers, which we believe will be invaluable as we accelerate the sales of AxisBiotix-Ps as well as driving our long-term ambitions of launching into other consumer areas.” said Board Chairman, Martin Hunt.
The company also announced the appointment of Manprit Singh Randhawa as CFO.
About Danielle Bekker
Danielle Bekker is to join the SkinBioTherapeutics Board as a non-executive director. She brings experience in direct-to-consumer marketing, including a focus on the use of influencers and digital media in the FMCG space having launched her own direct-to-consumer beverage business. She has a core set of skills that the Board believes will be invaluable to the Company as it commercializes its first product, AxisBiotix-Ps, and subsequent products e.g. acne. She also has strong supply chain management and governance skills, having worked with big corporates as well as eCommerce skills developed by founding her own business in the drinks industry.
About SkinBioTherapeutics plc
SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by Professor Catherine O’Neill and Professor Andrew McBain.
The Company is targeting several skin healthcare sectors, the most advanced of which are cosmetic skincare and food supplements to modulate the immune system by harnessing the gut-skin axis. In each area, SkinBioTherapeutics plans to exemplify its technology through human studies. The Company’s first product, AxisBiotix-Ps, a food supplement to address the symptoms of mild to moderate psoriasis was launched on 29 October – World Psoriasis Day.
For more information: https://www.skinbiotherapeutics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
